StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SHOULDN'T BE GOING DOWN EVERY DAY

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Feb 26, 2021 11:55am

108 Views

Post# 32671475

RE:RE:RE:RE:RE:RE:RE:RE:RE:SHOULDN'T BE GOING DOWN EVERY DAY

TrippingAgain2 wrote: Here is Correction: Tripp said they made over 1 million in the first 6 weeks of quarter 3 during the quarter 2 results which were horrendous. Then pumpers assumed throught his crafty wording that revenue would keep increasing throught the quarter 3. Thats when the outlandish revenue charts started that Tripp ended up calling out. This clearly showed the revenue in the last 6 weeks of quarter 3 was only 500K showing a CLEAR DECREASE...

Do all understand now....?

Show us that information as a quote - otherwise we are left to take your word as gospel which is a very dangerous thing to do...............